Cholinesterase Inhibitors: all 505 studies that test it
Page 5 of 6. Open to participants first (34), then studies with results posted, then the rest; newest registration first within each.
- Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth HormoneCompletedNCT00533065Not applicable
- Effect of Donepezil on the Reorganization of Cognitive Neural Network in Patients With Post-Stroke Cognitive ImpairmentStatus unknownNCT00530478Not applicable
- Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)Status unknownNCT00523666Phase 4
- Efficacy Study for Treatment of Dementia in Progressive Supranuclear PalsyStatus unknownNCT00522015Phase 2
- Memantine Versus Donepezil in Early Stages of Alzheimer's DiseaseCompletedNCT00505167Phase 4
- A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCICompletedNCT00483028Not applicable
- The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease PatientsCompletedNCT00480870Phase 4
- Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's DiseaseCompletedNCT00467766Not applicable
- Donepezil Double Blind Trial for ECT Memory DisfunctionStatus unknownNCT00465283Phase 4
- Galantamine for Cognitive Deficits in SchizophreniaCompletedNCT00463879Phase 2/3
- The Effect of Z-338 in Subjects With Functional DyspepsiaCompletedNCT00458328Phase 2
- Aricept to Improve Functional Tasks in Vascular DementiaStatus unknownNCT00457769Phase 1
- Galantamine Augmentation of Escitalopram for Treatment of DepressionTerminatedNCT00423969Phase 4
- Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's DiseaseCompletedNCT00423228Not applicable
- A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal DementiaCompletedNCT00416169Phase 2
- Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's DiseaseCompletedNCT00408525Phase 1
- The Impact of an Epidural Ropivacaine-Neostigmine Injection for Perineal Analgesia at the End of Labor.Status unknownNCT00407290Not applicable
- Efficacy and Safety of Itopride vs Placebo in HeartburnCompletedNCT00382577Phase 3
- Effects of Itopride on Gastric Motor and Sensory Functions in Healthy VolunteersCompletedNCT00370110Phase 1/2
- Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and GlycemiaCompletedNCT00370084Phase 1/2
- Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease PatientsTerminatedNCT00369603Phase 4
- SB-742457 And Donepezil In Alzheimer's DiseaseCompletedNCT00348192Phase 2
- Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's DiseaseCompletedNCT00338117Phase 3
- To Evaluate the Efficacy of Z-338 in Subjects With Functional DyspepsiaCompletedNCT00333372Phase 2
- To Evaluate the Efficacy and Safety in Subjects With Functional DyspepsiaCompletedNCT00323817Phase 2
- Galantamine for Cognition in People With SchizophreniaCompletedNCT00320736Phase 4
- A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.CompletedNCT00309725Phase 3
- A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.CompletedNCT00308399Phase 2/3
- Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's DiseaseCompletedNCT00305903Phase 4
- Long-term Safety and Efficacy of Galantamine in Alzheimer's DiseaseCompletedNCT00304629Phase 3
- An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.CompletedNCT00301574Phase 3
- The Effects of Z-338 in Subjects With and Without Functional DyspepsiaCompletedNCT00298194Phase 2
- The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)CompletedNCT00293176Phase 4
- Itopride in Functional Dyspepsia:a Dose Finding StudyCompletedNCT00272103Phase 2/3
- Brain Imaging and Mental Disorders of Aging InterventionCompletedNCT00267163Phase 4
- A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed DementiaCompletedNCT00261573Phase 3
- A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCompletedNCT00253227Phase 3
- Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release FormulationCompletedNCT00253214Phase 3
- A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCompletedNCT00253201Phase 3
- A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCompletedNCT00253188Phase 3
- Galantamine Versus Placebo in Childhood AutismCompletedNCT00252603Phase 3
- A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive ImpairmentCompletedNCT00240695Phase 3
- A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive ImpairmentCompletedNCT00236574Phase 3
- A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive ImpairmentCompletedNCT00236431Phase 3
- Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor TreatmentCompletedNCT00234637Phase 4
- Efficacy of Galantamine to Treat SchizophreniaTerminatedNCT00232349Phase 4
- Safety and Efficacy of Galantamine in Patients With Dementia With Lewy BodiesCompletedNCT00230997Phase 3
- EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00230568Phase 4
- Safety Study of Galantamine in Tic DisordersTerminatedNCT00226824Phase 4
- Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
- Prevention of Postoperative Delirium With DonepezilCompletedNCT00220896Phase 4
- An Open-Label Trial of Donepezil in Fragile X SyndromeCompletedNCT00220584Phase 1
- Galantamine in the Treatment of Post-Traumatic HeadacheStatus unknownNCT00219869Phase 4
- An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive DeficitsCompletedNCT00219245Phase 4
- An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseCompletedNCT00219232Phase 3
- Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled StudyCompletedNCT00216593Phase 3
- The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer TypeCompletedNCT00216515Phase 4
- A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's DiseaseCompletedNCT00216502Phase 3
- Galantamine Executive Function in Parkinson's DiseaseStatus unknownNCT00211588Not applicable
- The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in SchizophreniaTerminatedNCT00206947Phase 2
- Donepezil in Chronic Poststroke Aphasia: a Randomized Controlled TrialCompletedNCT00196690Phase 4
- A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar DisorderCompletedNCT00195845Phase 4
- Donepezil Treatment of Psychotic Symptoms in Dementia PatientsStatus unknownNCT00190021Phase 3
- Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular DiseaseCompletedNCT00188812Phase 3
- Donepezil in Preventing Delirium in Hospitalized ElderlyCompletedNCT00182884Phase 4
- Donepezil in the Prevention of Post-Operative Cognitive DeclineCompletedNCT00182845Phase 4
- Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive ImpairmentCompletedNCT00171795Phase 3
- The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With DementiaCompletedNCT00165815Phase 3
- Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular DementiaCompletedNCT00165763Phase 4
- Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD PatientsTerminatedNCT00165750Phase 4
- Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular DiseaseCompletedNCT00165737Phase 3
- Alzheimer's Disease Long-term Follow-up Study (ALF Study)CompletedNCT00165724Phase 4
- A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020CompletedNCT00165659Phase 2
- Treatment of Tardive Dyskinesia With GalantamineCompletedNCT00164242Phase 4
- An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit SymptomsCompletedNCT00161044Not applicable
- Rivastigmine For Methamphetamine Dependent IndividualsCompletedNCT00158210Phase 1
- CALM-ADStatus unknownNCT00142324Phase 4
- Study of the Distractibility Syndrome in Patients With Progressive Supranuclear PalsyStatus unknownNCT00139373Phase 2
- Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive ImpairmentTerminatedNCT00134953Phase 3
- Rivastigmine Capsules in Patients With Probable Vascular DementiaCompletedNCT00130338Phase 3
- Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional DyspepsiaCompletedNCT00112203Phase 3
- Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a MealCompletedNCT00112190Phase 3
- Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a MealCompletedNCT00112177Phase 3
- Long-term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional DyspepsiaCompletedNCT00110968Phase 3
- Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's DiseaseCompletedNCT00104442Phase 4
- The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive ImpairmentCompletedNCT00103948Phase 2
- YM443 in Subjects With Functional DyspepsiaCompletedNCT00102310Phase 2
- Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseCompletedNCT00099242Phase 3
- Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular DementiaCompletedNCT00099216Phase 3
- Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's DiseaseCompletedNCT00096473Phase 3
- Huperzine A in Alzheimer's DiseaseCompletedNCT00083590Phase 2
- Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's DiseaseCompletedNCT00082602Phase 3
- A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.CompletedNCT00077727Phase 3
- Sleep, Fatigue, and Dexamethosone in Children With LeukemiaCompletedNCT00075101Phase 3
- Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain TumorCompletedNCT00070161Phase 2
- Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett SyndromeStatus unknownNCT00069550Phase 3
- Memory and Mental Health in AgingCompletedNCT00043589Not applicable
- A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's DiseaseCompletedNCT00035204Phase 4
- A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular DementiaCompletedNCT00035191Phase 3
- Donepezil to Treat Dementia in Parkinson's DiseaseCompletedNCT00030979Phase 4